SOC status:Duty analyst on shift

UK Cyber Defence
VulnerabilityDeferred

CVE-2026-77930

EvoScientist 0.1.0 before 0.2.5 contains an approval bypass vulnerability that allows attackers to run host shell commands by delegating them to async sub-agents lacking an interrupt_on gate.

CRITICAL 9.3EPSS 0.69%

Does this matter?

High impact if exploited, but EPSS currently rates exploitation as unlikely (0.69%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.

Description

EvoScientist 0.1.0 before 0.2.5 contains an approval bypass vulnerability that allows attackers to run host shell commands by delegating them to async sub-agents lacking an interrupt_on gate. Attackers can plant instructions in ingested content such as fetched web pages, so the agent calls start_async_task and runs commands with user privileges and environment secrets.

CVSS 4.0
9.3 CRITICALCVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/M
EPSS
0.69% probability · 52th percentile
Public exploits
None in Exploit-DB
CISA KEV
Not listed
Weakness
CWE-862
Source
disclosure@vulncheck.com
EPSS trend
0%3%5%20 October 2026: 0.44%26 October 2026: 0.69%20 October 202626 October 2026

EPSS moved from 0.4% on 20 October 2026 to 0.7% on 26 October 2026.

Source: NVD record, EPSS from FIRST.org, KEV from CISA, exploits from Exploit-DB. Refreshed daily. Download this record as JSON.